Novel flanking DNA sequences enhance FOXO1a DNA binding affinity but do not alter DNA bending

Biochemistry

Volumn 47, Issue 26, 2008, Pages 6809-6818

  Sidhu, Alpa ^a   Miller, Patrick J ^a   Johanson, Kelly E ^a   Hollenbach, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDING (DEFORMATION); BINDING ENERGY; DNA; GENES; HORMONES; INSULIN; NUCLEIC ACIDS; ORGANIC ACIDS; PROTEINS; STOICHIOMETRY; TRANSCRIPTION; TRANSCRIPTION FACTORS;

AMERICAN CHEMICAL SOCIETY (ACS); BINDING AFFINITIES; BIOLOGICAL FUNCTIONS; DNA BENDING; DNA BINDING AFFINITY; DNA-BINDING; ENDOGENOUS GENES; FAMILY MEMBERS; FLANKING SEQUENCES; GROWTH FACTORS; LUCIFERASE REPORTER; SYSTEMATIC EVALUATION; TRANSCRIPTIONAL TARGETS;

DNA SEQUENCES;

CURVED DNA; TRANSCRIPTION FACTOR FKHR;

ARTICLE; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; DNA BINDING; DNA FLANKING REGION; DNA SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STOICHIOMETRY;

5' FLANKING REGION; BASE SEQUENCE; DNA; FORKHEAD TRANSCRIPTION FACTORS; PROTEIN BINDING; TRANSCRIPTION, GENETIC;

EID: 46049106746     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702495m     Document Type: Article

References (49)

1. Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., and Naeve, C. W. (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-5112.
2. Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., and Rauscher, F. J. (1995) The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 1522-1535.
3. Furuyama, T., Nakazawa, T., Nakano, I., and Mori, N. (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629-634.
4. Lantz, K. A., and Kaestner, K. H. (2005) Winged-helix transcription factors and pancreatic development. Clin. Sci. (London) 108, 195-204.
5. Hosaka, T., Biggs, W. H., III, Tieu, D., Boyer, A. D., Varki, N. M., Cavenee, W. K., and Arden, K. C. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U.S.A. 101, 2975-2980.
6. Morris, J. B., Kenney, B., Huynh, H., and Woodcock, E. A. (2005) Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists. Endocrinology 146, 4370-4376.
7. Gajiwala, K. S., and Burley, S. K. (2000) Winged helix proteins. Curr. Opin. Struct. Biol. 10, 110-116.
8. Anderson, M. J., Viars, C. S., Czekay, S., Cavenee, W. K., and Arden, K. C. (1998) Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47, 187-199.
9. Richards, J. S., Sharma, S. C., Falender, A. E., and Lo, Y. H. (2002) Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol. Endocrinol. 16, 580-599.
10. Shi, F., and LaPolt, P. S. (2003) Relationship between FoxO1 protein levels and follicular development, atresia, and luteinization in the rat ovary. J. Endocrinol. 179, 195-203.
11. Zhang, X., Gan, L., Pan, H., Guo, S., He, X., Olson, S. T., Mesecar, A., Adam, S., and Unterman, T. G. (2002) Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J. Biol. Chem. 277, 45276-45284.
12. Nakae, J., Kitamura, T., Silver, D. L., and Accili, D. (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367.
13. Durham, S. K., Suwanichkul, A., Scheimann, A. O., Yee, D., Jackson, J. G., Barr, F. G., and Powell, D. R. (1999) FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 140, 3140-3146.
14. Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T. (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184-17192.
15. Kwon, H. S., Huang, B., Unterman, T. G., and Harris, R. A. (2004) Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 53, 899-910.
16. Hatta, M., Daitoku, H., Matsuzaki, H., Deyama, Y., Yoshimura, Y., Suzuki, K., Matsumoto, A., and Fukamizu, A. (2002) Regulation of alkaline phosphatase promoter activity by forkhead transcription factor FKHR. Int. J. Mol. Med. 9, 147-152.
17. Onuma, H., Vander Kooi, B. T., Boustead, J. N., Oeser, J. K., and O'Brien, R. M. (2006) Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin. Mol. Endocrinol. 20, 2831-2847.
18. Bois, P. R., and Grosveld, G. C. (2003) FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J. 22, 1147-1157.
19. Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H., Nishino, I., and Ezaki, O. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123.
20. Dong, X. Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R. X., Chung, L. W., Zhou, W., and Dong, J. T. (2006) FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 66, 6998-7006.
21. Wang, B., Lin, D., Li, C., and Tucker, P. (2003) Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278, 24259-24268.
22. Overdier, D. G., Porcella, A., and Costa, R. H. (1994) The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol. Cell. Biol. 14, 2755-2766.
23. Costa, R. H., Kalinichenko, V. V., and Lim, L. (2001) Transcription factors in mouse lung development and function. Am. J. Physiol. 280, L823-L838.
24. Ma, Y., Geerdes, D. W., and Vogt, P. K. (2000) Oncogenic transformation by the FOX protein Qin requires DNA binding. Oncogene 19, 4815-4821.
25. Lim, L., Zhou, H., and Costa, R. H. (1997) The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo. Proc. Natl. Acad. Sci. U.S.A. 94, 3094-3099.
26. Pierrou, S., Hellqvist, M., Samuelsson, L., Enerback, S., and Carlsson, P. (1994) Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J. 13, 5002-5012.
27. Roux, J., Pictet, R., and Grange, T. (1995) Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol. 14, 385-396.
28. Kaufmann, E., and Knochel, W. (1996) Five years on the wings of fork head. Mech. Dev. 57, 3-20.
29. Boura, E., Silhan, J., Herman, P., Vecer, J., Sulc, M., Teisinger, J., Obsilova, V., and Obsil, T. (2007) Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J. Biol. Chem. 282, 8265-8275.
30. Hollenbach, A. D., Sublett, J. E., McPherson, C. J., and Grosveld, G. (1999) The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18, 3702-3711.
31. Hollenbach, A. D., McPherson, C. J., Lagutina, I., and Grosveld, G. (2002) The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3. Biochim. Biophys. Acta 1574, 321-328.
32. Kim, J., Zwieb, C., Wu, C., and Adhya, S. (1989) Bending of DNA by gene-regulatory proteins: construction and use of a DNA bending vector. Gene 85, 15-23.
33. Thompson, J. F., and Landy, A. (1988) Empirical estimation of protein-induced DNA bending angles: applications to lambda site-specific recombination complexes. Nucleic Acids Res. 16, 9687-9705.
34. Miller, P. J., and Hollenbach, A. D. (2007) The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis. Biochim. Biophys. Acta 1770, 1450-1458.
35. Bouvet, P. (2001) Determination of nucleic acid recognition sequences by SELEX. Methods Mol. Biol. 148, 603-610.
36. Epstein, J., Cai, J., Glaser, T., Jepeal, L., and Maas, R. (1994) Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J. Biol. Chem. 269, 8355-8361.
37. Chalepakis, G., and Gruss, P. (1995) Identification of DNA recognition sequences for the Pax3 paired domain. Gene 162, 267-270.
38. Phelan, S. A., and Loeken, M. R. (1998) Identification of a new binding motif for the paired domain of Pax-3 and unusual characteristics of spacing of bipartite recognition elements on binding and transcription activation. J. Biol. Chem. 273, 19153-19159.
39. Dementhon, K., and Saupe, S. J. (2005) DNA-binding specificity of the IDI-4 basic leucine zipper factor of Podospora anserina defined by systematic evolution of ligands by exponential enrichment (SELEX). Eukaryot. Cell 4, 476-483.
40. Wu, H. M., and Crothers, D. M. (1984) The locus of sequence-directed and protein-induced DNA bending. Nature 308, 509-513.
41. Dahlquist, F. W. (1978) The meaning of Scatchard and Hill plots. Methods Enzymol. 48, 270-299.
42. Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L., and Sellers, W. R. (2002) A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2, 81-91.
43. Katsani, K. R., Hajibagheri, M. A., and Verrijzer, C. P. (1999) Co-operative DNA binding by GAGA transcription factor requires the conserved BTB/POZ domain and reorganizes promoter topology. EMBO J. 18, 698-708.
44. Williams, T., and Tjian, R. (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 5, 670-682.
45. Jin, C., and Liao, X. (1999) Backbone dynamics of a winged helix protein and its DNA complex at different temperatures: changes of internal motions in genesis upon binding to DNA. J. Mol. Biol. 292, 641-651.
46. Gajiwala, K. S., Chen, H., Cornille, F., Roques, B. P., Reith, W., Mach, B., and Burley, S. K. (2000) Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature 403, 916-921.
47. Weigelt, J., Climent, I., Dahlman-Wright, K., and Wikstrom, M. (2001) Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4). Biochemistry 40, 5861-5869.
48. Hatta, M., and Cirillo, L. A. (2007) Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1. J. Biol. Chem. 282, 35583-35593.
49. Werner, M. H., and Burley, S. K. (1997) Architectural transcription factors: proteins that remodel DNA. Cell 88, 733-736.